The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This analysis looks at the amount of funding for vaccines and the number of vaccine doses that have been donated to the global COVID-19 vaccine effort and standardizes these donations based on the size of donor economies.
Two years into the COVID-19 pandemic, the public is split on their readiness to return to normal, with many worried about the consequences of lifting restrictions and of not lifting them. At this point, the pandemic is not a top issue for voters in November's midterm elections . Most parents are not confident in the safety of the vaccine for kids under 5.
As federal, state, and local authorities move to roll back COVID-19 restrictions, a new KFF COVID-19 Vaccine Monitor survey finds many people ready to get back to normal but a public also nervous about the potential consequences. Large shares of the public are worried about the implications of both keeping and easing pandemic restrictions – with partisans split on which direction worries them the most. Overall, majorities say they worry about the potential consequences of…
The share of nursing home staffers who have been fully vaccinated against COVID-19 varies considerably by state, from 70 percent in Ohio to 99 percent in Maine, Rhode Island, New York and Massachusetts, a new KFF analysis finds. The national average is 84 percent. The analysis of federal nursing home data for the week ending Jan. 30 comes as providers strive to comply with a federal mandate that health care workers whose employers participate in…
Of the 19 million U.S. children under 5, half are children of color, making this group more diverse than the U.S. population overall. There is also significant variation across the country.
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries, including questions related to out-of-pocket costs, the COVID-19 vaccine, telehealth, extended supplies of medication, skilled nursing facility stays, and issues for people in private Medicare Advantage plans.
3 in 10 of Those with Children Under 5 Expect to Get Them a Shot Right Away Once Eligible 1 in 4 Parents Say Their Student Had to Quarantine in January Due to COVID-19 Infection or Exposure; Overall 4 in 10 Report Some Education Disruption Growing shares of parents say that their eligible children have gotten at least one dose of a COVID-19 vaccine, and three in ten parents with children under age 5 say…
This Vaccine Monitor survey finds an increase in the share of parents reporting their child has received a COVID-19 vaccine, with 61% of parents of 12-17-year olds and 33% of 5-11-year-olds now saying their child has gotten at least one shot. Three in ten parents of children under the age of 5, a group that has not yet been approved to get a vaccine, say they’ll get their child vaccinated right away.
6 in 10 Who Tried to Purchase an At-Home Test and a Third Who Sought an In-Person Test Say It Was Difficult to Find, Though Most Were Eventually Able to Get a Test Black and Hispanic Adults are More Likely Than White Adults to Worry About Omicron’s Effects, Including Becoming Seriously Ill or Missing Work Due to Infection The latest KFF COVID-19 Vaccine Monitor report shows that 42% of all adults nationwide have received a…
This report shows that 42% of all adults have received a COVID-19 booster, including about 70% of those who are likely booster-eligible. More than three quarters (77%) have received at least one dose of a COVID-19 vaccine. The poll also explores the public's experiences getting at-home and in-person COVID-19 tests and other issues.
© 2026 KFF